Whittier, CANCT05028348Now EnrollingIRB Ready

Multiple Myeloma Clinical Trial in Whittier, CA

Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Whittier. Study-provided care at no cost to qualified participants.

Sponsored by Stichting European Myeloma Network

Quick Self-Assessment

See if you qualify for this Whittier location

Preparing your pre-screening questions...

Expert Care in Whittier

Access multiple myeloma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple myeloma treatment provided free

Apply for This Whittier Location

Check if you qualify for this multiple myeloma clinical trial in Whittier, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Whittier

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Whittier site if eligible
  4. 4Begin participation

About This Multiple Myeloma Study in Whittier

This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).

Sponsor: Stichting European Myeloma Network

Who Can Participate

Inclusion Criteria

Relapsed or refractory MM with measurable disease per IMWG guidelines as defined by at least 1 of the following: 1. Serum M-protein ≥0.5 g/dL (≥5 g/L) by serum protein electrophoresis (SPEP) or, for immunoglobulin (Ig) A or D myeloma, by quantitative serum IgA or IgD levels ≥ 0.5 g/dL. 2. Urinary M-protein excretion ≥200 mg/24 hours 3. Serum free light chain (FLC) ≥100 mg/L, provided that the FLC ratio is abnormal (normal FLC ratio: 0.26 to 1.65) 2. Received at least 1 and no more than 4 prior anti-MM lines of therapy. Induction therapy followed by stem cell transplant and consolidation/maintenance therapy will be considered as 1 line of therapy. 3. Prior therapy that includes ≥ consecutive cycles of lenalidomide and a proteasome inhibitor given alone or in combination 4. Prior therapy with an anti-CD38 mAb as part of their immedicate last treatment prior to study entry (Before protocol version2.0, patient with any prior therapy with an anti-CD38 mAb w

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Whittier?

Yes, this clinical trial (NCT05028348) has an active research site in Whittier, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Myeloma Treatment Options in Whittier, CA

If you're searching for multiple myeloma treatment options in Whittier, CA, this clinical trial (NCT05028348) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Whittier research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple myeloma clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Whittier, CA

See all multiple myeloma clinical trials recruiting in Whittier — not just this study.

Browse Multiple Myeloma Trials in Whittier →

Browse More Trials by Condition

Multiple Myeloma TrialsAll Conditions →

Ready to Join in Whittier?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Whittier, CA